![As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study](https://cdn.cancerletter.com/media/2024/01/01044631/40-44-Rick-and-Erica-Kaitz-in-summer-2011.jpg)
![As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study](https://cdn.cancerletter.com/media/2024/01/01044631/40-44-Rick-and-Erica-Kaitz-in-summer-2011.jpg)
Cover Story
Free
Here is what we know: A surgical device used to perform about 100,000 hysterectomies and myomectomies every year in the U.S. has been shown to spread cells from undetected or missed uterine cancers—rapidly upstaging the disease.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Trending Stories
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission